国产一区二区三区视频精品-国产一区二区三区视频在线观看-国产一区二区三区四区五区-国产一区二区三区四区五区精品-国产一区二区三区无码免费-国产一区二区三区在线

德國Fresenius Helios
德國醫療保健巨頭費森尤斯公司（Fresenius）表示將以15億歐元（約18.1億美元）的價格收購德國私營連鎖醫院HeliosKliniken。此舉使其成為德國最大的醫院運營公司之一。

　 費森尤斯集團此次從Helios創始家族手中購得94％的股份，而剩余6％的股份則留給了Helios的管理層。Helios總共有24家連鎖醫院，約9300個床位。通過這一收購，費森尤斯將得以拉近其與德國實力雄厚的老對頭RhoenKlinikumAG之間的距離，后者擁有11800張床位。而費森尤斯的雄心并沒有停留在此，公司首席執行官UlfSchneider在接受《金融時報》（德國版）采訪時表示，在Helios之后，公司還將進一步在醫院業務領域進行收購。而RhoenKlinikum監事會成員EugenMuench則表示，不懼怕來自費森尤斯的挑戰。Muench稱，目前各家公司的市場份額都很小，還有90％的市場等待拓展。
 

　 據悉，德國2000家由非營利的公共機構管理的醫院中，大部分都不同程度地出現了財務困難，并且正在尋求買方，這就為諸如費森尤斯以及RhoenKlinikum這樣的公司提供了機遇。

　 費森尤斯公司于2001年收購德國醫院運營商WittgensteinerKliniken后，涉足醫院業務。但是，費森尤斯在這一領域并未像公司在其他領域那樣大舉獲得成功。費森尤斯去年總收入為62.3億美元，而來自醫院部門的收入則約為9.8億美元。

　 為了對這一交易進行融資，費森尤斯將在2006年中期之前發行7億歐元左右的債券。而瑞士信貸第一波士頓和摩根士丹利則已為該公司提供了7億歐元的過渡性融資。費森尤斯由于剛在今年5月份斥資35億美元收購了美國腎病透析服務公司RenalCareGroupInc，公司資產負債表負擔有所增加。

　 創立于1912年的費森尤斯總部設在德國巴登洪堡，業務涉及藥品、營養、醫療器械、醫院管理等多項與醫療衛生事業相關的產業，并在世界各地設有分支機構、分公司和辦事處。
 
HELIOS Hospital Group
The HELIOS Hospital Group ranks among the largest and most medically advanced hospital groups in Germany. After its acquisition by the Fresenius Group in December 2005, HELIOS Hospital Corporation formed part of the Fresenius ProServe company. As from January 1, 2008 HELIOS figures as an independant business segment within the Fresenius Group. It is responsible for the operation and management of hospitals and specializes in acute medicine and rehabilitation.

The Group consists of 57 owned hospitals with 17,300 beds, including five maximum care hospitals in Erfurt, Berlin-Buch, Wuppertal, Schwerin and Krefeld. The Group's 30.000 employees perform around 530.000 inpatient treatments annually. The HELIOS Hospital Group offers expertise in all areas and at all levels of clinical care, including maximum care. HELIOS manages clinics, specialised in acute medicine, as well as hospitals with great expertise in rehabilitation. Its headquarters are in Berlin.

Medical excellence
In 2005, HELIOS Hospitals provided inpatient medical services in 897 out of 954 case groups in the 2006 G-DRG system. As a leading hospital operator within the Fresenius Group, HELIOS is committed to delivering excellence in clinical and nursing care. The Group provides high quality, state-of-the-art medical care which makes significant contributions to the advancement of medical science. Patients benefit, as HELIOS offers the most advanced and verifiably best diagnosis and treatment methods.

The HELIOS Research Center coordinates and funds clinical research within the company in cooperation with the Max Delbrück Center for Molecular Medicine (MDC), Berlin, Charité University Hospital, Berlin, and the University of Witten-Herdecke. Nine HELIOS Hospitals are teaching hospitals in academic partnerships with universities.